Newsletter | August 29, 2023

08.29.23 -- The Global Landscape For Synthetic Biology In Biopharma Through 2035

Drug Discovery Online Newsletter | August 29, 2023 | View web version here.
Featured Editorial
Industry Insights
Precision Powder-In-Capsule Microdosing Accelerates Drug Development

Precision powder microdosing makes it possible to quickly get formulations to the clinic, saving time, money, and use of limited APIs.

Converting From ELISA To Biacore SPR Assays

This article provides general guidance on how to convert an existing ELISA assay to a Biacore SPR assay and, by doing so, shows how you can get results in less than half the time compared with ELISA.

Method Development: Managing A Diverse Range Of APIs

See how the team developed analytical methods to support preclinical and future GMP production under tight timelines.

Partnering On An Innovative Hydrogel-Based Treatment For Glioblastoma

Treatments for glioblastoma multiforme (GBM) are in high demand. Learn more about the new possibilities for increased dosing and diffusion capabilities offered by nanoformed APIs.

Manufacturing Dry Powder Inhaled Formulations By Spray Drying

Kimberly Shepard, Ph.D., principal engineer in R&D, addresses the challenges associated with spray-drying late-stage lung cancer treatments, including proteins, peptides, and mAbs.

Most Popular News
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.